High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population

被引:7
|
作者
Lee, S
Hong, SW
Moon, WC
Oh, MR
Lee, JK
Ahn, CW
Cha, BS
Kim, KR
Lee, HC
Lim, SK
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] GoodGene Inc, Seoul, South Korea
关键词
D O I
10.1089/thy.2005.15.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contributes to the development of thyroid cancers in two different ways. First, somatic rearrangements of RET with variable activation genes are frequently found in papillary thyroid carcinomas. Second, germ-line point mutations are responsible for the development of medullary thyroid carcinomas and multiple endocrine neoplasia type 2 (MEN 2). There are several conflicting reports on the influences of RET expression and RET/PTC rearrangements on the clinical outcome of thyroid cancers. Therefore, the wild-type RET gene expression and RET/PTC-1, RET/PTC-2, RET/PTC-3 rearrangements were examined in thyroid carcinomas and other thyroid diseases. Materials and Methods: Thirty-six papillary thyroid carcinomas (PTCs), 8 follicular thyroid carcinomas (FTCs), 4 anaplastic thyroid carcinomas (ATC), 7 follicular adenomas (FAs), 23 hyperplasias, 6 normal thyroid tissues, and 39 normal portions from each tumor were included in this study. Reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical analyses were used to identify the RET gene and RET/PTC rearrangements. Results: From the RT-PCR analysis, 68.9% of the PTCs, a single case of FTC, and 22.2% of the hyperplasias expressed the RET gene. No RET gene expression was observed in ATCs, FAs, or normal thyroid tissues. One RET/PTC-1 and one RET/PTC-2 rearrangement were detected in the PTCs. No RET/PTC-3 rearrangement was detected in any specimen. The immunohistochemical results revealed that 66.7% of PTCs, 28.6% of FAs, and 18.2% of hyperplastic thyroid tissue specimens showed high levels of RET protein expression. Neither the normal thyroid tissues nor the FTCs and ATC, showed high levels of RET protein expression. The two methods are agreed in PTC and hyperplastic nodules, but not in FA and FTC. Conclusion: PTCs among Koreans rarely showed RET/PTC rearrangements, but commonly showed increased RET gene expression. Compared to earlier reports indicating that the expression of the RET gene was limited to PTCs, the RET gene was also expressed in hyperplasias in this study.
引用
收藏
页码:259 / 266
页数:8
相关论文
共 50 条
  • [1] Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas
    Øystein Fluge
    Dagny RF Haugen
    Lars A Akslen
    Anne Marstad
    Massimo Santoro
    Alfredo Fusco
    Jan E Varhaug
    Johan R Lillehaug
    Oncogene, 2001, 20 : 885 - 892
  • [2] Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas
    Fluge, O
    Haugen, DRF
    Akslen, LA
    Marstad, A
    Santoro, M
    Fusco, A
    Varhaug, JE
    Lillehaug, JR
    ONCOGENE, 2001, 20 (07) : 885 - 892
  • [3] High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population
    Kang, Dae-Young
    Kim, Kyung-Hee
    Kim, Jin-Man
    Kim, Seok-Hyung
    Kim, Ji-Young
    Baik, Haing-Woon
    Kim, Yong-Sung
    THYROID, 2007, 17 (11) : 1031 - 1038
  • [4] High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas
    Lam, KY
    Lo, CY
    Leung, PS
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (06) : 741 - 745
  • [5] Detection of RET/PTC oncogene rearrangements in Korean papillary thyroid carcinomas
    Chung, JH
    Hahm, JR
    Min, YK
    Lee, MS
    Lee, MK
    Kim, KW
    Nam, SJ
    Yang, JH
    Ree, HJ
    THYROID, 1999, 9 (12) : 1237 - 1243
  • [6] High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas
    Martínez, I
    Mantilla, A
    Medrano, ME
    Hernández, R
    Hernández, DM
    Lazos, M
    Santiago, H
    González, B
    Hidalgo, A
    Salcedo, M
    ENDOCRINE PATHOLOGY, 2001, 12 (02) : 113 - 123
  • [7] High prevalence of RET tyrosine kinase activation in mexican patients with papillary thyroid carcinomas
    Ivan Martínez
    Alejandra Mantilla
    María E. Medrano
    Rogelio Hernández
    Dulce María Hernández
    Minerva Lazos
    Hector Santiago
    Beatriz González
    Alfredo Hidalgo
    Mauricio Salcedo
    Endocrine Pathology, 2001, 12 : 113 - 123
  • [8] Overexpression of wild-type c-RET and zero prevalence of RET/PTC rearrangements are associated with papillary thyroid cancer (PTC) in Kuwait
    El-Abdallah, Abir A.
    Junaid, Thamradeen A.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2011, 90 (01) : 61 - 65
  • [9] RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
    Learoyd, DL
    Messina, M
    Zedenius, J
    Guinea, AI
    Delbridge, LW
    Robinson, BG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10): : 3631 - 3635
  • [10] Histomorphologic and clinical correlation of RET expression in papillary thyroid carcinomas
    Herrmann, ME
    Wojcik, EM
    Husain, AN
    Martinez, B
    Bakhos, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 537 - 537